References
- Stone GW, Ellis SG, Cannon L, et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 2005;294:1215-23. https://doi.org/10.1001/jama.294.10.1215
- Mehran R, Dangas G, Abizaid AS, et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999;100:1872-8. https://doi.org/10.1161/01.CIR.100.18.1872
- Kuntz RE, Baim DS. Defining coronary restenosis. Newer clinical and angiographic paradigms. Circulation 1993;88:1310-23. https://doi.org/10.1161/01.CIR.88.3.1310
- Win HK, Caldera AE, Maresh K, et al. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA 2007;297:2001-9. https://doi.org/10.1001/jama.297.18.2001
- Aoyama T, Ishii H, Toriyama T, et al. Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis. Circ J 2008;72:56-60. https://doi.org/10.1253/circj.72.56
- Goel SS, Dilip Gajulapalli R, Athappan G, et al. Management of drug eluting stent in-stent restenosis: a systematic review and meta-analysis. Catheter Cardiovasc Interv 2016;87:1080-91. https://doi.org/10.1002/ccd.26151
- Dangas GD, Claessen BE, Caixeta A, Sanidas EA, Mintz GS, Mehran R. In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol 2010;56:1897-907. https://doi.org/10.1016/j.jacc.2010.07.028
- Solinas E, Dangas G, Kirtane AJ, et al. Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention. Am J Cardiol 2008;102:311-5. https://doi.org/10.1016/j.amjcard.2008.03.060
- Alfonso F, Cequier A, Angel J, et al. Value of the American College of Cardiology/American Heart Association angiographic classification of coronary lesion morphology in patients with in-stent restenosis. Insights from the Restenosis Intra-stent Balloon angioplasty versus elective Stenting (RIBS) randomized trial. Am Heart J 2006;151:681.e1-681.e9. https://doi.org/10.1016/j.ahj.2005.10.014
- Alfonso F. Treatment of drug-eluting stent restenosis the new pilgrimage: quo vadis? J Am Coll Cardiol 2010;55:2717-20. https://doi.org/10.1016/j.jacc.2010.03.026
- Byrne RA, Joner M, Tada T, Kastrati A. Restenosis in bare metal and drug-eluting stents: distinct mechanistic insights from histopathology and optical intravascular imaging. Minerva Cardioangiol 2012;60:473-89.
- Kimura T, Yokoi H, Nakagawa Y, et al. Three-year follow-up after implantation of metallic coronary-artery stents. N Engl J Med 1996;334:561-6. https://doi.org/10.1056/NEJM199602293340903
- Byrne RA, Iijima R, Mehilli J, et al. Durability of antirestenotic efficacy in drug-eluting stents with and without permanent polymer. JACC Cardiovasc Interv 2009;2:291-9. https://doi.org/10.1016/j.jcin.2008.11.015
- Collet CA, Costa JR, Abizaid A, et al. Assessing the temporal course of neointimal hyperplasia formation after different generations of drug-eluting stents. JACC Cardiovasc Interv 2011;4:1067-74.
- Alfonso F, Perez-Vizcayno MJ, Cruz A, et al. Treatment of patients with in-stent restenosis. EuroIntervention 2009;5 Suppl D:D70-8.
- Nakazawa G, Otsuka F, Nakano M, et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol 2011;57:1314-22. https://doi.org/10.1016/j.jacc.2011.01.011
- Fujii K, Mintz GS, Kobayashi Y, et al. Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis. Circulation 2004;109:1085-8. https://doi.org/10.1161/01.CIR.0000121327.67756.19
- Alfonso F, Sandoval J, Cardenas A, Medina M, Cuevas C, Gonzalo N. Optical coherence tomography: from research to clinical application. Minerva Med 2012;103:441-64.
- Angiolillo DJ, Sabata M, Alfonso F, Macaya C. "Candy wrapper" effect after drug-eluting stent implantation: deja vu or stumbling over the same stone again? Catheter Cardiovasc Interv 2004;61:387-91. https://doi.org/10.1002/ccd.10765
- Kang SJ, Mintz GS, Akasaka T, et al. Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation. Circulation 2011;123:2954-63. https://doi.org/10.1161/CIRCULATIONAHA.110.988436
- Cassese S, Byrne RA, Tada T, et al. Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography. Heart 2014;100:153-9. https://doi.org/10.1136/heartjnl-2013-304933
- Habara S, Mitsudo K, Kadota K, et al. Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis. JACC Cardiovasc Interv 2011;4:149-54. https://doi.org/10.1016/j.jcin.2010.10.012
- Nicolais C, Lakhter V, Virk HU, et al. Therapeutic options for in-stent restenosis. Curr Cardiol Rep 2018;20:7. https://doi.org/10.1007/s11886-018-0952-4
- Hernandez RA, Macaya C, Iniguez A, et al. Midterm outcome of patients with asymptomatic restenosis after coronary balloon angioplasty. J Am Coll Cardiol 1992;19:1402-9. https://doi.org/10.1016/0735-1097(92)90594-D
- Pinto DS, Stone GW, Ellis SG, et al. Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial. J Am Coll Cardiol 2006;48:32-6. https://doi.org/10.1016/j.jacc.2006.02.060
- Kim YH, Her AY, Rha SW, et al. Routine angiographic follow-up versus clinical follow-up after percutaneous coronary intervention in acute myocardial infarction. Yonsei Med J 2017;58:720-30. https://doi.org/10.3349/ymj.2017.58.4.720
- Kim YH, Her AY, Rha SW, et al. Routine angiographic follow-up versus clinical follow-up in patients with multivessel coronary artery diseases following percutaneous coronary intervention with drug-eluting stents: a nested case-control study within a Korean population. Coron Artery Dis 2017;28:307-14. https://doi.org/10.1097/MCA.0000000000000479
- Lopez-Palop R, Pinar E, Lozano I, Saura D, Pico F, Valdes M. Utility of the fractional flow reserve in the evaluation of angiographically moderate in-stent restenosis. Eur Heart J 2004;25:2040-7. https://doi.org/10.1016/j.ehj.2004.07.016
- Nam CW, Rha SW, Koo BK, et al. Usefulness of coronary pressure measurement for functional evaluation of drug-eluting stent restenosis. Am J Cardiol 2011;107:1783-6. https://doi.org/10.1016/j.amjcard.2011.02.328
- Mukherjee D, Reginelli JP, Moliterno DJ, et al. Unexpected mortality reduction with abciximab for in-stent restenosis. J Invasive Cardiol 2000;12:540-4.
- Moustapha A, Assali AR, Sdringola S, et al. Abciximab administration and clinical outcomes after percutaneous intervention for in-stent restenosis. Catheter Cardiovasc Interv 2002;56:184-7. https://doi.org/10.1002/ccd.10166
- Hausleiter J, Kastrati A, Mehilli J, et al. Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial. Circulation 2004;110:790-5. https://doi.org/10.1161/01.CIR.0000138935.17503.35
- Kufner S, Hausleiter J, Ndrepepa G, et al. Long-term risk of adverse outcomes and new malignancies in patients treated with oral sirolimus for prevention of restenosis. JACC Cardiovasc Interv 2009;2:1142-8. https://doi.org/10.1016/j.jcin.2009.08.015
- Macander PJ, Roubin GS, Agrawal SK, Cannon AD, Dean LS, Baxley WA. Balloon angioplasty for treatment of in-stent restenosis: feasibility, safety, and efficacy. Cathet Cardiovasc Diagn 1994;32:125-31. https://doi.org/10.1002/ccd.1810320206
- Alfonso F, Byrne RA, Rivero F, Kastrati A. Current treatment of in-stent restenosis. J Am Coll Cardiol 2014;63:2659-73. https://doi.org/10.1016/j.jacc.2014.02.545
- Alfonso F, Perez-Vizcayno MJ, Hernandez R, et al. Long-term outcome and determinants of event-free survival in patients treated with balloon angioplasty for in-stent restenosis. Am J Cardiol 1999;83:1268-70, A9. https://doi.org/10.1016/S0002-9149(99)00071-5
- Mehran R, Mintz GS, Popma JJ, et al. Mechanisms and results of balloon angioplasty for the treatment of in-stent restenosis. Am J Cardiol 1996;78:618-22. https://doi.org/10.1016/S0002-9149(96)00381-5
- Alfonso F, Garcia P, Fleites H, et al. Repeat stenting for the prevention of the early lumen loss phenomenon in patients with in-stent restenosis. Angiographic and intravascular ultrasound findings of a randomized study. Am Heart J 2005;149:e1-8.
- Alfonso F, Perez-Vizcayno MJ, Gomez-Recio M, et al. Implications of the "watermelon seeding" phenomenon during coronary interventions for in-stent restenosis. Catheter Cardiovasc Interv 2005;66:521-7. https://doi.org/10.1002/ccd.20524
- Byrne RA, Neumann FJ, Mehilli J, et al. Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial. Lancet 2013;381:461-7. https://doi.org/10.1016/S0140-6736(12)61964-3
- Montorsi P, Galli S, Fabbiocchi F, Trabattoni D, Ravagnani PM, Bartorelli AL. Randomized trial of conventional balloon angioplasty versus cutting balloon for in-stent restenosis. Acute and 24-hour angiographic and intravascular ultrasound changes and long-term follow-up. Ital Heart J 2004;5:271-9.
- Adamian M, Colombo A, Briguori C, et al. Cutting balloon angioplasty for the treatment of in-stent restenosis: a matched comparison with rotational atherectomy, additional stent implantation and balloon angioplasty. J Am Coll Cardiol 2001;38:672-9. https://doi.org/10.1016/S0735-1097(01)01458-9
- Albiero R, Silber S, Di Mario C, et al. Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the restenosis cutting balloon evaluation trial (RESCUT). J Am Coll Cardiol 2004;43:943-9. https://doi.org/10.1016/j.jacc.2003.09.054
- Kufner S, Joner M, Schneider S, et al. Neointimal modification with scoring balloon and efficacy of drug-coated balloon therapy in patients with restenosis in drug-eluting coronary stents: a randomized controlled trial. JACC Cardiovasc Interv 2017;10:1332-40. https://doi.org/10.1016/j.jcin.2017.04.024
- Mehran R, Dangas G, Mintz GS, et al. Treatment of in-stent restenosis with excimer laser coronary angioplasty versus rotational atherectomy: comparative mechanisms and results. Circulation 2000;101:2484-9. https://doi.org/10.1161/01.CIR.101.21.2484
- Sanchez PL, Rodriguez-Alemparte M, Colon-Hernandez PJ, et al. Directional coronary atherectomy vs. rotational atherectomy for the treatment of in-stent restenosis of native coronary arteries. Catheter Cardiovasc Interv 2003;58:155-61. https://doi.org/10.1002/ccd.10399
- Sharma SK, Kini A, Mehran R, Lansky A, Kobayashi Y, Marmur JD. Randomized trial of rotational atherectomy versus balloon angioplasty for diffuse in-stent restenosis (ROSTER). Am Heart J 2004;147:16-22. https://doi.org/10.1016/j.ahj.2003.07.002
- vom Dahl J, Dietz U, Haager PK, et al. Rotational atherectomy does not reduce recurrent in-stent restenosis: results of the angioplasty versus rotational atherectomy for treatment of diffuse in-stent restenosis trial (ARTIST). Circulation 2002;105:583-8. https://doi.org/10.1161/hc0502.103347
- Ichimoto E, Kadohira T, Nakayama T, De Gregorio J. Long-term clinical outcomes after treatment with excimer laser coronary atherectomy for in-stent restenosis of drug-eluting stent. Int Heart J 2018;59:14-20. https://doi.org/10.1536/ihj.16-638
- Kobayashi Y, Teirstein P, Linnemeier T, Stone G, Leon M, Moses J. Rotational atherectomy (stentablation) in a lesion with stent underexpansion due to heavily calcified plaque. Catheter Cardiovasc Interv 2001;52:208-11. https://doi.org/10.1002/1522-726X(200102)52:2<208::AID-CCD1049>3.0.CO;2-H
- Alfonso F, Sandoval J, Nolte C. Calcified in-stent restenosis: a rare cause of dilation failure requiring rotational atherectomy. Circ Cardiovasc Interv 2012;5:e1-2. https://doi.org/10.1161/CIRCINTERVENTIONS.111.966606
- Leon MB, Teirstein PS, Moses JW, et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 2001;344:250-6. https://doi.org/10.1056/NEJM200101253440402
- Waksman R, White RL, Chan RC, et al. Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation 2000;101:2165-71. https://doi.org/10.1161/01.CIR.101.18.2165
- Holmes DR Jr, Teirstein P, Satler L, et al. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. JAMA 2006;295:1264-73. https://doi.org/10.1001/jama.295.11.1264
- Stone GW, Ellis SG, O'Shaughnessy CD, et al. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. JAMA 2006;295:1253-63. https://doi.org/10.1001/jama.295.11.1253
- Torguson R, Sabate M, Deible R, et al. Intravascular brachytherapy versus drug-eluting stents for the treatment of patients with drug-eluting stent restenosis. Am J Cardiol 2006;98:1340-4. https://doi.org/10.1016/j.amjcard.2006.06.027
- Mintz GS, Hoffmann R, Mehran R, et al. In-stent restenosis: the Washington Hospital Center experience. Am J Cardiol 1998;81:7E-13E. https://doi.org/10.1016/S0002-9149(98)00190-8
- Alfonso F, Zueco J, Cequier A, et al. A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis. J Am Coll Cardiol 2003;42:796-805. https://doi.org/10.1016/S0735-1097(03)00852-0
- Stefanini GG, Holmes DR Jr. Drug-eluting coronary-artery stents. N Engl J Med 2013;368:254-65. https://doi.org/10.1056/NEJMra1210816
- Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 2007;370:937-48. https://doi.org/10.1016/S0140-6736(07)61444-5
- Kastrati A, Mehilli J, von Beckerath N, et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 2005;293:165-71.
- Dibra A, Kastrati A, Alfonso F, et al. Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials. J Am Coll Cardiol 2007;49:616-23. https://doi.org/10.1016/j.jacc.2006.10.049
- Alfonso F, Perez-Vizcayno MJ, Hernandez R, et al. A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon angioplasty versus elective sirolimus-eluting Stenting (RIBS-II) trial. J Am Coll Cardiol 2006;47:2152-60. https://doi.org/10.1016/j.jacc.2005.10.078
- Alfonso F, Perez-Vizcayno MJ, Hernandez R, et al. Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study. J Am Coll Cardiol 2008;52:1621-7. https://doi.org/10.1016/j.jacc.2008.08.025
- Byrne RA, Cassese S, Windisch T, et al. Differential relative efficacy between drug-eluting stents in patients with bare metal and drug-eluting stent restenosis; evidence in support of drug resistance: insights from the ISAR-DESIRE and ISAR-DESIRE 2 trials. EuroIntervention 2013;9:797-802. https://doi.org/10.4244/EIJV9I7A132
- Latib A, Mussardo M, Ielasi A, et al. Long-term outcomes after the percutaneous treatment of drug-eluting stent restenosis. JACC Cardiovasc Interv 2011;4:155-64.
- Kastrati A, Byrne R. New roads, new ruts: lessons from drug-eluting stent restenosis. JACC Cardiovasc Interv 2011;4:165-7. https://doi.org/10.1016/j.jcin.2010.11.008
- Alfonso F, Perez-Vizcayno MJ, Dutary J, et al. Implantation of a drug-eluting stent with a different drug (switch strategy) in patients with drug-eluting stent restenosis. Results from a prospective multicenter study (RIBS III [Restenosis Intra-stent: Balloon angioplasty versus drug-eluting Stent]). JACC Cardiovasc Interv 2012;5:728-37. https://doi.org/10.1016/j.jcin.2012.03.017
- Alfonso F, Garcia J, Perez-Vizcayno MJ, et al. New stent implantation for recurrences after stenting for in-stent restenosis: implications of a third metal layer in human coronary arteries. J Am Coll Cardiol 2009;54:1036-8. https://doi.org/10.1016/j.jacc.2009.04.082
- Rivero F, Bastante T, Cuesta J, Benedicto A, Restrepo JA, Alfonso F. Treatment of in-stent restenosis with bioresorbable vascular scaffolds: optical coherence tomography insights. Can J Cardiol 2015;31:255-9. https://doi.org/10.1016/j.cjca.2014.11.017
- Jamshidi P, Nyffenegger T, Sabti Z, et al. A novel approach to treat in-stent restenosis: 6-and 12-month results using the everolimus-eluting bioresorbable vascular scaffold. EuroIntervention 2016;11:1479-86. https://doi.org/10.4244/EIJV11I13A287
- Scheller B, Hehrlein C, Bocksch W, et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 2006;355:2113-24. https://doi.org/10.1056/NEJMoa061254
- Unverdorben M, Vallbracht C, Cremers B, et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation 2009;119:2986-94. https://doi.org/10.1161/CIRCULATIONAHA.108.839282
- Alfonso F, Perez-Vizcayno MJ, Cardenas A, et al. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent). J Am Coll Cardiol 2014;63:1378-86. https://doi.org/10.1016/j.jacc.2013.12.006
- Rittger H, Brachmann J, Sinha AM, et al. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study. J Am Coll Cardiol 2012;59:1377-82. https://doi.org/10.1016/j.jacc.2012.01.015
- Xu B, Gao R, Wang J, et al. A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: results from the PEPCAD China ISR trial. JACC Cardiovasc Interv 2014;7:204-11.
- Indermuehle A, Bahl R, Lansky AJ, et al. Drug-eluting balloon angioplasty for in-stent restenosis: a systematic review and meta-analysis of randomised controlled trials. Heart 2013;99:327-33. https://doi.org/10.1136/heartjnl-2012-302945
- Alfonso F, Perez-Vizcayno MJ, Cardenas A, et al. A prospective randomized trial of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents: the RIBS IV randomized clinical trial. J Am Coll Cardiol 2015;66:23-33. https://doi.org/10.1016/j.jacc.2015.04.063
- Siontis GC, Stefanini GG, Mavridis D, et al. Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis. Lancet 2015;386:655-64. https://doi.org/10.1016/S0140-6736(15)60657-2
- Giacoppo D, Gargiulo G, Aruta P, Capranzano P, Tamburino C, Capodanno D. Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients. BMJ 2015;351:h5392.
Cited by
- Koronare Restenose vol.44, pp.1, 2018, https://doi.org/10.1007/s00059-018-4777-0
- MicroRNAs: New Biomarkers for the progression of Coronary Artery Diseases vol.185, pp.None, 2018, https://doi.org/10.1051/e3sconf/202018503039
- Clinical profile and angiographic patterns of patients undergoing treatment for in-stent restenosis and outcomes associated with the treatment vol.9, pp.3, 2018, https://doi.org/10.4103/rcm.rcm_21_20
- Effect of Intravascular Ultrasound–Guided Drug-Eluting Stent Implantation : 5-Year Follow-Up of the IVUS-XPL Randomized Trial vol.13, pp.1, 2020, https://doi.org/10.1016/j.jcin.2019.09.033
- Prediabetes predicts adverse cardiovascular outcomes after percutaneous coronary intervention: a meta-analysis vol.40, pp.1, 2018, https://doi.org/10.1042/bsr20193130
- Drug-eluting balloon: is it useful? vol.72, pp.1, 2020, https://doi.org/10.1186/s43044-020-00116-7
- Predictive value of inflammatory factors on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease : A protocol for systematic review and meta-analysis vol.100, pp.13, 2018, https://doi.org/10.1097/md.0000000000025356
- Intracoronary brachytherapy for the treatment of recurrent drug-eluting stent in-stent restenosis: A systematic review and meta-analysis vol.13, pp.4, 2018, https://doi.org/10.4330/wjc.v13.i4.95
- Surface engineering at the nanoscale: A way forward to improve coronary stent efficacy vol.5, pp.2, 2018, https://doi.org/10.1063/5.0037298
- Risk factors associated with intra‑stent restenosis after percutaneous coronary intervention vol.22, pp.4, 2021, https://doi.org/10.3892/etm.2021.10575
- Impact of chronic kidney disease on long-term outcomes for coronary in-stent restenosis after drug-coated balloon angioplasty vol.78, pp.6, 2021, https://doi.org/10.1016/j.jjcc.2021.08.010